AIM: To retrospectively evaluate the detectability of @entity5 recurrence with CT and MRI after superselective conventional transcatheter arterial chemoembolization (cTACE) for @entity157 ( @entity157 ). METHODS: The detectability of @entity5 recurrence with CT and @entity18497 -enhanced MRI obtained within 30 days (mean, 16.9    10.1 days) were compared in 38 @entity1 with recurrent @entity157 after superselective cTACE. @entity5 recurrence was divided into local and distant recurrence. Local recurrence was also divided into intratumoral and peritumoral recurrence. RESULTS: @entity5 recurrence (maximum diameter, 19.7    10.1 mm) was demonstrated by images   12.4    11.7 months after cTACE. CT could depict 16 (76.2%) of 21 intratumoral recurrences in 12 @entity1 and 14 (53.8%) of 26 peritumoral recurrences in 11, as well as 39 (55.7%) of 70 distant recurrences in 15 (75%) of 20 @entity1 . Arterial phase MRI could depict 20 (95.2%) of 21 intratumoral recurrences in 14 @entity1 and all 26 (100%) peritumoral recurrences in 21, as well as 60 (85.7%) distant recurrences in all 20 (100%) @entity1 . The detectability of @entity5 recurrence with MRI was significantly higher than that with CT (p = 0.00549). On MRI, pseudolesions were observed in five (13.2%) @entity1 and artifacts in the arterial phase in five (13.2%). Regarding the diagnostic performance, CT was superior to MRI in two (5.3%) @entity1 and MRI was superior to CT in 19 (50%). They were almost equal in 17 (44.7%). CONCLUSION: The detectability of @entity5 recurrence after superselective cTACE with @entity18497 -enhanced MRI was superior to that of CT.

Evaluation of XXXX recurrence after superselective conventional transcatheter arterial chemoembolization for @entity157 : comparison of CT and @entity18497 -enhanced MRI.

@entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'Tumor'] @entity157 :: ('MESH:D006528', 'Disease') :: ['HCC', 'hepatocellular carcinoma'] @entity1 :: ('9606', 'Species') :: ['patients'] @entity18497 :: ('MESH:C073590', 'Chemical') :: ['gadoxetate disodium']
@entity5 :: (MESH:D009369,Disease) :: ['tumor']
